Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

HIKMA

  • FDA Approval
  • Oct. 25, 2024, 11:59 UTC
  • 41
  • 0 comments

FDA approve HEPARIN SODIUM

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Oct. 25, 2024, 11:59 UTC
  • 42
  • 0 comments

FDA approve HEPARIN SODIUM

Comment Full text

HETERO LABS LTD III

  • FDA Approval
  • Oct. 25, 2024, 11:59 UTC
  • 40
  • 0 comments

FDA approve NEVIRAPINE

Comment Full text

MACLEODS PHARMS LTD

  • FDA Approval
  • Oct. 25, 2024, 11:59 UTC
  • 40
  • 0 comments

FDA approve ESOMEPRAZOLE MAGNESIUM

Comment Full text

ASPEN GLOBAL INC

  • FDA Approval
  • Oct. 25, 2024, 11:59 UTC
  • 39
  • 0 comments

FDA approve HEPARIN SODIUM

Comment Full text

HETERO LABS LTD V

  • FDA Approval
  • Oct. 24, 2024, 08:47 UTC
  • 46
  • 0 comments

FDA approve MYCOPHENOLATE MOFETIL

Comment Full text

HETERO LABS LTD V

  • FDA Approval
  • Oct. 24, 2024, 08:47 UTC
  • 36
  • 0 comments

FDA approve MYCOPHENOLATE MOFETIL

Comment Full text

MSN

  • FDA Approval
  • Oct. 24, 2024, 08:47 UTC
  • 48
  • 0 comments

FDA approve DEFERASIROX

Comment Full text

OSMOTICA PHARM US

  • FDA Approval
  • Oct. 24, 2024, 08:47 UTC
  • 41
  • 0 comments

FDA approve CARBAMAZEPINE

Comment Full text

LEXENPHARM

  • FDA Approval
  • Oct. 24, 2024, 08:47 UTC
  • 43
  • 0 comments

FDA approve FORMOTEROL FUMARATE

Comment Full text
  • Previous
  • 282
  • 283
  • 284
  • 285
  • 286
  • Next

Search

News categories

  • Technical Exchange News(10600)
  • Event(2019)
  • SEC News(184783)
  • FDA Approval(9847)
  • Company Report(721)
  • Business News(122458)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin